*Source of carbohydrate, diluent for IV INF:*
Dosage as per requirement
⛔ Contraindications
Glucose-galactose malabsorption syndrome.
⚠️ Precautions & Warnings
Dextrose tolerance may be impaired in patients with renal failure and in the early post-traumatic state or in those with severe sepsis. Dextrose infusions, even if isoosmotic, should not be mixed with whole blood; haemolysisand clumping has occurred.
📚 Official Regulatory & Clinical References
Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.
Immunasol 5% IV Infusion — DRAP Registration Number: 014233
Immunasol 10% IV Infusion — DRAP Registration Number: 014234
Related Medicines
Medicines related to this brand, grouped by relevance.